Aescin

CAS : 6805-41-0

Ref. 3D-OA07948

Informations sur le produit

• Nom: Aescin
• Synonymes: EscinAesculus, (2S,3S,4S,5R,6R)-6-[[(4S,6aR,6bS,8R,8aR,9R,10R,14bR)-9-acetoxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(Z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy]tetrahydropyran-2-carboxylic acid, (3beta,5xi,9xi,16alpha,18xi,21alpha,22alpha)-22-(acetyloxy)-16,24,28-trihydroxy-21-{[(2Z)-2-methylbut-2-enoyl]oxy}olean-12-en-3-yl beta-D-glucopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->4)]-beta-D-glucopyranosiduronic acid, 3,5-Epoxypicene, escin deriv., Aescusan, Ba 2672, Chestnuts extract, Escigenin, 3-(4-O-β-<span class="text-smallcaps">D</smallcap>-glucopyranosyl-2-O-β-<smallcap>D</smallcap>-xylopyranosyl-β-<smallcap>D</span>-glucopyranuronoside), 3-hydroxy-2-methylbutyrate, acetate, Escin, Escusan, Eskuzan, Extract of horse chestnut, Flebostasin Retard, Horse chestnut extract, Oleanane, escin deriv., Venocin, β-Escinic acid
• CAS: 6805-41-0

Description

Beta-Aescin (also known as€ beta-escin) is a saponin produced by the horse chestnut tree, Aesculus hippocastanum, with most published reports relating to the pharmacological properties that it shows. It is reported that beta-aescin is a safe and very tolerable drug in the treatment of post thrombotic syndrome and chronic venous insufficiency. Aescin shows promise in the treatment of arthritis and appears to have potential as an anti-cancer drug. In fact, beta-aescin is active on glioblastoma-initiating cells (GIC), which have the ability to initiate glioblastoma growth. Glioblastoma multiform is the most abundant primary tumor of the human nervous system. Beta-aescin was more efficient in diminishing GIC growth compared to present clinically used drugs.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 1,131.26 g/mol
• Formule: C₅₅H₈₅O₂₄
• Couleur/Forme: Powder